In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 87392-07-2, name is (S)-Tetrahydrofuran-2-carboxylic acid, introducing its new discovery. Recommanded Product: (S)-Tetrahydrofuran-2-carboxylic acid
The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 87392-07-2, and how the biochemistry of the body works.Recommanded Product: (S)-Tetrahydrofuran-2-carboxylic acid
Reference:
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem